<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">avk</journal-id><journal-title-group><journal-title xml:lang="ru">Архивъ внутренней медицины</journal-title><trans-title-group xml:lang="en"><trans-title>The Russian Archives of Internal Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2226-6704</issn><issn pub-type="epub">2411-6564</issn><publisher><publisher-name>“SINAPS” LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20514/2226-6704-2025-15-5-367-375</article-id><article-id custom-type="edn" pub-id-type="custom">OWEXTW</article-id><article-id custom-type="elpub" pub-id-type="custom">avk-2081</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLE</subject></subj-group></article-categories><title-group><article-title>Инфекционный эндокардит у пациентов на программном гемодиализе</article-title><trans-title-group xml:lang="en"><trans-title>Infective Endocarditis in Patients on Maintenance Hemodialysis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6187-7525</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пономарева</surname><given-names>Е. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Ponomareva</surname><given-names>E. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пономарева Елена Юрьевна — кандидат медицинских наук, доцент кафедры госпитальной терапии лечебного факультета</p><p>Саратов</p></bio><bio xml:lang="en"><p>Elena Yu. Ponomareva — Candidate of Medical Sciences, Associate Professor at the Department of Hospital Therapy, Faculty of Medicine</p><p>Saratov</p></bio><email xlink:type="simple">ponomareva_elena1@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2260-0958</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Седов</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Sedov</surname><given-names>D. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Седов Дмитрий Сергеевич — кандидат медицинских наук, ассистент кафедры госпитальной терапии лечебного факультета</p><p>Саратов</p></bio><bio xml:lang="en"><p>Dmitrii S. Sedov — Candidate of Medical Sciences, Assistant Professor at the Department of Hospital Therapy, Faculty of Medicine</p><p>Saratov</p><p> </p></bio><email xlink:type="simple">dr.dmitrii.sedov@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Саратовский ГМУ им. В.И. Разумовского» Минздрава России, кафедра госпитальной терапии лечебного факультета</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saratov State Medical University named after V.I. Razumovsky, Ministry of Health of Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Саратовский ГМУ им. В.И. Разумовского» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saratov State Medical University named after V.I. Razumovsky, Ministry of Health of Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>25</day><month>09</month><year>2025</year></pub-date><volume>15</volume><issue>5</issue><fpage>367</fpage><lpage>375</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пономарева Е.Ю., Седов Д.С., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Пономарева Е.Ю., Седов Д.С.</copyright-holder><copyright-holder xml:lang="en">Ponomareva E.Y., Sedov D.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medarhive.ru/jour/article/view/2081">https://www.medarhive.ru/jour/article/view/2081</self-uri><abstract><p>Аннотация. Актуальность проблемы определяется увеличением распространенности заместительной почечной терапии (ЗПТ) и связанных с ней инфекционных осложнений, в том числе инфекционного эндокардита (ИЭ) — заболевания с высокой смертностью и неблаг оприятным прогнозом. Цель исследования. Изучить особенности течения, клинические характеристики, лабораторно-инструментальные параметры и исходы ИЭ у пациентов, получающих лечение программным гемодиализом (ПГД). Материал и методы. Обследованы 371 пациент с определенным ИЭ (модифицированные DUKE-критерии), госпитализированные с 2000 по 2024 г. Из них 23 (6,2 %) пациента получали ПГД в амбулаторных диализных центрах Саратовской области. Группу сравнения составили 348 пациентов с ИЭ, не нуждающихся в ЗПТ. Результаты. Медиана возраста пациентов с ИЭ на ПГД составила 51 [38; 56] год. Диализный стаж 13 [2;58,5] мес. Частота встречаемости ИЭ в исследуемой когорте составила 6,2 % (23 из 371 пациента с ИЭ). Положительная гемокультура получена у 14 (60,8 %) пациентов с ИЭ на ПГД, золотистый стафилококк выделен у 9 (39 %) и энтерококк — у 5 (21,7 %). У большинства пациентов на ПГД отмечена левосторонняя локализация ИЭ (17 (73,9 %)), как и в группе сравнения. В группе пациентов с ИЭ на ПГД оказались значимо выше частота острого течения заболевания, сахарного диабета, неврологических осложнений (р&lt;0,05), а также более высокие количественные значения маркеров системного воспаления: С-реактивного протеина, прокальцитонина (р&lt;0,05). Индекс коморбидности Charlson был выше, анемия и тромбоцитопения более выражены у пациентов с ИЭ на ПГД (р&lt;,05). Госпитальная летальность при ИЭ на ПГД составила 52,17 % против 17,8 % в группе сравнения (OR 4,228, 95 % ДИ: 1,784 — 10,02; (р &lt;0,05)). Заключение. ИЭ у пациентов на ПГД — инфекционное заболевание, ассоциированное с медицинским вмешательством, вызываемое, главным образом, золотистым стафилококком. ИЭ на ПГД характеризуется острым течением, выраженностью воспалительной реакции, высокой летальностью. В связи с повышенным риском развития ИЭ у пациентов на ПГД из-за эксплуатации сосудистого доступа и неблагоприятным прогнозом, пациентам показаны строгие меры асептики, эхокардиографическое исследование при клиническом подозрении на ИЭ (необъяснимой лихорадке). В ведении пациентов с ИЭ на ПГД существуют особенности антибактериальной терапии, диализной терапии и профилактики с целью минимизации факторов риска и т.п., что требует мультидисциплинарного взаимодействия специалистов.</p></abstract><trans-abstract xml:lang="en"><p>Background. The relevance of the problem is determined by the increasing prevalence of renal replacement therapy and associated infectious complications, including infective endocarditis (IE) — a disease with high mortality and poor prognosis. Aim. To study the clinical characteristics, laboratory and instrumental parameters, and outcomes of IE in patients undergoing maintenance hemodialysis (HD). Materials and methods. A total of 371 patients with definite IE (modified DUKE criteria) hospitalized between 2000 and 2024 were examined. Of these, 23 patients received maintenance HD at outpatient dialysis centers in the Saratov region. The control group consisted of 348 patients with IE who did not require renal replacement therapy. Results. The mean age of dialysis patients with IE was 51 [38; 56] years, with a dialysis duration of 13 [2; 58.5] months. The prevalence of IE in the studied cohort was 6.2 % (23 out of 371 patients with IE). Positive blood cultures were obtained in 14 (60.8 %) of patients with IE on maintenance HD, with Staphylococcus aureus isolated in 9 (39 %) and Enterococcus in 5 (21.7 %) cases. Left-sided IE localization was observed in the majority of maintenance HD patients (17 (73.9 %)), similar to the comparison group. Patients with IE on maintenance HD exhibited a significantly higher frequency of acute disease progression, diabetes mellitus, and neurological complications (p &lt; 0.05), along with elevated quantitative levels of systemic inflammation markers, such as C-reactive protein and procalcitonin (p &lt; 0.05). The Charlson comorbidity index was higher, and anemia and thrombocytopenia were more severe in patients with IE on maintenance HD (p &lt; 0.05). Hospital mortality in IE patients on maintenance HD was 52.17 %, compared to 17.8 % in the comparison group (OR 4.228, 95 % CI: 1.784–10.02; p &lt; 0.05). Conclusion. IE in patients on maintenance HD is a healthcare-associ ated infection primarily caused by Staphylococcus aureus. IE in maintenance HD patients is characterized by an acute course, severe inflammatory response, and high mortality. Due to the increased risk of IE in maintenance HD patients related to vascular access use and poor prognosis, strict aseptic measures and echocardiographic evaluation in cases of clinical suspicion of IE (e.g., unexplained fever) are recommended. The management of IE in maintenance HD patients requires specific app roaches to antibiotic therapy, dialysis treatment, and prevention to minimize risk factors, necessitating multidisciplinary collaboration among specialists.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инфекционный эндокардит</kwd><kwd>сердечно-сосудистые заболевания</kwd><kwd>программный гемодиализ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>infective endocarditis</kwd><kwd>cardiovascular disease</kwd><kwd>maintenance hemodialysis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Авторы заявляют об отсутствии финансирования при проведении исследования.</funding-statement><funding-statement xml:lang="en">The authors declare no funding for this study.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Demin A.A., Kobalava Zh.D., Skopin I.I. et al. Infective endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021. Russian Cardiology Journal. 2022;27(10):5233. doi: 10.15829/1560-4071-2022-5233 [In Russian].</mixed-citation><mixed-citation xml:lang="en">Demin A.A., Kobalava Zh.D., Skopin I.I. et al. Infective endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021. Russian Cardiology Journal. 2022;27(10):5233. doi: 10.15829/1560-4071-2022-5233 [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Delgado V., Ajmone Marsan N., de Waha S. et al. 2023 ESC guidelines for the management of endocarditis: developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM). European Heart Journal. 2023; 44(39): 3948–4042. doi: 10.1093/eurheartj/ehad193.</mixed-citation><mixed-citation xml:lang="en">Delgado V., Ajmone Marsan N., de Waha S. et al. 2023 ESC guidelines for the management of endocarditis: developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM). European Heart Journal. 2023; 44(39): 3948–4042. doi: 10.1093/eurheartj/ehad193.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Sadeghi M., Behdad S., Shahsanaei F. Infective endocarditis and its short and long-term prognosis in hemodialysis patients: a systematic review and meta-analysis. Current Problems in Cardiology. 2021; 46(3): 100680. doi: 10.1016/j.cpcardiol.2020.100680.</mixed-citation><mixed-citation xml:lang="en">Sadeghi M., Behdad S., Shahsanaei F. Infective endocarditis and its short and long-term prognosis in hemodialysis patients: a systematic review and meta-analysis. Current Problems in Cardiology. 2021; 46(3): 100680. doi: 10.1016/j.cpcardiol.2020.100680.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ludvigsen L.U., Dalgaard L.S., Wiggers H. et al. Infective endocarditis in patients receiving chronic hemodialysis: a 21-year observational cohort study in Denmark. American Heart Journal. 2016; 182: 36–43. doi: 10.1016/j.ahj.2016.08.012.</mixed-citation><mixed-citation xml:lang="en">Ludvigsen L.U., Dalgaard L.S., Wiggers H. et al. Infective endocarditis in patients receiving chronic hemodialysis: a 21-year observational cohort study in Denmark. American Heart Journal. 2016; 182: 36–43. doi: 10.1016/j.ahj.2016.08.012.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ding U., Ooi L., Wu H. H. L ., Chinnadurai R. Infective endocarditis in patients receiving hemodialysis: a current review. Kidney Diseases (Basel). 2024;10(6):519–530. doi: 10.1159/000540513.</mixed-citation><mixed-citation xml:lang="en">Ding U., Ooi L., Wu H. H. L ., Chinnadurai R. Infective endocarditis in patients receiving hemodialysis: a current review. Kidney Diseases (Basel). 2024;10(6):519–530. doi: 10.1159/000540513.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Пономарева Е.Ю., Кошелева Н.А., Седов Д.С. Мультидисциплинарный подход к ведению пациентки с правосторонним инфекционным эндокардитом на программном гемодиализе. Архивъ внутренней медицины. 2023;13(5):371–376. doi: 10.20514/2226-6704-2023-13-5-371-376.</mixed-citation><mixed-citation xml:lang="en">Ponomareva E.Yu., Kosheleva N.A., Sedov D.S. Multidisciplinary approach to managing a patient with right-sided infective endocarditis on programmed hemodialysis. The Russian Archives of Internal Medicine. 2023;13(5):371–376. doi: 10.20514/2226-6704-2023-13-5-371-376 [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Pericàs J., Llopis J., Jiménez-Exposito M. et al. Infective endocarditis in patients on chronic hemodialysis. Journal of the American College of Cardiology. 2021;77(13):1629–1640. doi: 10.1016/j.jacc.2021.02.014.</mixed-citation><mixed-citation xml:lang="en">Pericàs J., Llopis J., Jiménez-Exposito M. et al. Infective endocarditis in patients on chronic hemodialysis. Journal of the American College of Cardiology. 2021;77(13):1629–1640. doi: 10.1016/j.jacc.2021.02.014.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lok C.E., Huber T.S., Lee T. et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. American Journal of Kidney Diseases. 2020;75(4 Suppl 2):S1–S164. doi: 10.1053/j.ajkd.2019.12.001.</mixed-citation><mixed-citation xml:lang="en">Lok C.E., Huber T.S., Lee T. et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. American Journal of Kidney Diseases. 2020;75(4 Suppl 2):S1–S164. doi: 10.1053/j.ajkd.2019.12.001.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bentata Y. Physiopathological approach to infective endocarditis in chronic hemodialysis patients: left heart versus right heart involvement. Renal Failure. 2017;39(1):432–439. doi: 10.1080/0886022x.2017.1305410.</mixed-citation><mixed-citation xml:lang="en">Bentata Y. Physiopathological approach to infective endocarditis in chronic hemodialysis patients: left heart versus right heart involvement. Renal Failure. 2017;39(1):432–439. doi: 10.1080/0886022x.2017.1305410.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Волгина Г., Котенко О., Артюхина Л. И др. Инфекционный эндокардит у пациентов на гемодиализе. Врач. 2011; 13:16–22.</mixed-citation><mixed-citation xml:lang="en">Volgina G., Kotenko O., Artyukhina L. et al. Infective endocarditis in patients on hemodialysis. Vrach. 2011; 13:16–22 [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Loutradis C., Sarafidis P.A., Papadopoulos C.E., Papagianni A., Zoccali C. The ebb and flow of echocardiographic cardiac function parameters in relationship to hemodialysis treatment in patients with ESRD. Journal of the American Society of Nephrology. 2018;29(5):1372–1381. doi: 10.1681/ASN.2017101102.</mixed-citation><mixed-citation xml:lang="en">Loutradis C., Sarafidis P.A., Papadopoulos C.E., Papagianni A., Zoccali C. The ebb and flow of echocardiographic cardiac function parameters in relationship to hemodialysis treatment in patients with ESRD. Journal of the American Society of Nephrology. 2018;29(5):1372–1381. doi: 10.1681/ASN.2017101102.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ashley C., Dunleavy A. The Renal Drug Handbook: The Ultimate Prescribing Guide for Renal Practitioners. 5th ed. CRC Press; 2018. doi: 10.1201/9780429460418.</mixed-citation><mixed-citation xml:lang="en">Ashley C., Dunleavy A. The Renal Drug Handbook: The Ultimate Prescribing Guide for Renal Practitioners. 5th ed. CRC Press; 2018. doi: 10.1201/9780429460418.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bäck C., Hornum M., Møller C.J. H.et al. Cardiac surgery in patients with end-stage renal disease on dialysis. Scandinavian Cardiovascular Journal. 2017;51(6):334–338. doi: 10.1080/14017431.2017.1384565.</mixed-citation><mixed-citation xml:lang="en">Bäck C., Hornum M., Møller C.J. H.et al. Cardiac surgery in patients with end-stage renal disease on dialysis. Scandinavian Cardiovascular Journal. 2017;51(6):334–338. doi: 10.1080/14017431.2017.1384565.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Doulton T., Sabharwal N., Cairns H.S. et al. Infective endocarditis in dialysis patients: new challenges and old. Kidney International. 2003;64(2):720–727. doi: 10.1046/j.1523-1755.2003.00136.x.</mixed-citation><mixed-citation xml:lang="en">Doulton T., Sabharwal N., Cairns H.S. et al. Infective endocarditis in dialysis patients: new challenges and old. Kidney International. 2003;64(2):720–727. doi: 10.1046/j.1523-1755.2003.00136.x.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
